University of Toronto, Faculty of Medicine, Department of Surgery, 149 College Street, Toronto M5T 1P5, Ontario, Canada.
University of Toronto, Faculty of Medicine, Department of Medical Biophysics, 101 College Street, Toronto M5G 1L7, Ontario, Canada.
Photodiagnosis Photodyn Ther. 2021 Sep;35:102353. doi: 10.1016/j.pdpdt.2021.102353. Epub 2021 May 26.
Isolated lung metastases in sarcoma and colorectal cancer patients are inadequately treated with current standard therapies. In Vivo Lung Perfusion, a novel platform, could overcome limitations to photodynamic therapy treatment volumes by using low cellular perfusate, removing blood, theoretically allowing greater light penetration. To develop personalized photodynamic therapy protocols requires in silico light propagation simulations based on optical properties and maximal permissible photodynamic threshold dose of lung tissue. This study presents quantification of optical properties for two perfusates and the photodynamic threshold for 5-ALA and Chlorin e6.
Porcine and human lungs were placed on Ex Vivo Lung Perfusion, and perfused with acellular solution or blood. Isotropic diffusers were placed within bronchi and on lung surface for light transmission measurements, from which absorption and light scattering properties were calculated at multiple wavelengths. Separately, pigs were injected with 5-ALA or Chlorin e6, and lung tissue was irradiated at increasing doses. Resultant lesion sizes were measured by CT and histology to quantify the photodynamic threshold.
Low cellular perfusate reduced the tissue absorption coefficient significantly, increasing penetration depth of light by 3.3 mm and treatment volumes 3-fold. The photodynamic threshold for lung exposed to 5-ALA was consistent with other malignancies. Chlorin e6 levels were undetectable in lung tissue and did not demonstrate photodynamic-induced necrosis.
Light penetration with low cellular perfusate is significantly greater and could enable treatments for diffuse disease. This data aids photodynamic treatment planning and will guide clinical translation of photodynamic therapy protocols in the lung, especially during lung perfusion.
肉瘤和结直肠癌患者的孤立性肺转移瘤,经当前标准疗法治疗效果不佳。新型平台“In Vivo Lung Perfusion”可通过使用低细胞灌流液、清除血液来克服光动力疗法治疗体积的局限性,理论上可增加光穿透深度。为制定个性化光动力治疗方案,需要基于肺组织的光学特性和最大允许光动力阈值剂量进行计算机模拟光传播。本研究提出了两种灌流液的光学特性定量分析以及 5-ALA 和 Chlorin e6 的光动力阈值。
将猪和人肺置于离体肺灌注系统中,并用无细胞溶液或血液进行灌注。各向同性扩散器分别置于支气管内和肺表面,用于进行光传输测量,从中计算出多个波长的吸收和光散射特性。另外,猪被注射 5-ALA 或 Chlorin e6,然后对肺组织进行递增剂量的辐照。通过 CT 和组织学测量病变大小,定量光动力阈值。
低细胞灌流液显著降低组织吸收系数,增加光穿透深度 3.3 毫米,治疗体积增加 3 倍。暴露于 5-ALA 的肺的光动力阈值与其他恶性肿瘤一致。肺组织中未检测到 Chlorin e6 水平,且未显示光动力诱导的坏死。
低细胞灌流液的光穿透显著增加,可为弥漫性疾病提供治疗。该数据有助于光动力治疗计划,并将指导光动力疗法在肺中的临床转化,尤其是在肺灌注期间。